Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$424K Sell
1,416
-51
-3% -$14.9K 0.01% 314
2023
Q3
$420K Buy
1,467
+2
+0.1% +$570 0.02% 295
2023
Q2
$411K Buy
1,465
+1
+0.1% +$260 0.01% 291
2023
Q1
$374K Sell
1,464
-77
-5% -$22.4K 0.01% 288
2022
Q4
$511K Buy
1,541
+63
+4% +$19.9K 0.02% 253
2022
Q3
$410K Buy
1,478
+71
+5% +$20K 0.02% 265
2022
Q2
$371K Buy
1,407
+560
+66% +$144K 0.02% 279
2022
Q1
$203K Buy
+847
New +$198K 0.01% 377
2021
Q2
Sell
-866
Closed -$209K 384
2021
Q1
$209K Buy
+866
New +$193K 0.01% 340

Other funds holding CI

GW & Wade's CI Position: Q4 2023 in Review

GW & Wade reduced its Cigna (CI) stake by 3.5% in Q4 2023, selling an estimated $14.9K and leaving 1,416 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #314.

GW & Wade first reported a position in CI in Q1 2021 and has held it in 9 quarters since. The position peaked at $511K in Q4 2022. 1,626 funds tracked by Wall St. Rank hold CI as of Q4 2023.

  • GW & Wade held 1,416 shares of Cigna worth $424K as of Q4 2023.
  • GW & Wade sold 51 Cigna shares in Q4 2023, an estimated $14.9K.
  • Cigna made up 0.01% of GW & Wade's portfolio in Q4 2023, its #314 holding.
  • GW & Wade first reported a position in Cigna in Q1 2021 and has held it in 9 quarters since.
  • GW & Wade's Cigna position peaked at $511K in Q4 2022.
  • 1,626 funds tracked by Wall St. Rank held Cigna as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.